Moon J. Noh, Ph.D.

Moon J. Noh, Ph.D.

Chief Executive Officer

Dr. Moon J. Noh has been with Kolon TissueGene for over 16 years. Prior to his role here, Dr. Noh was the Director of the Biotechnology Lab at Kolon Central Research Park. Dr. Noh holds a Ph.D. and M.S. from the Korea Advanced Institute of Science and Technology in Molecular Biology.

Sung Han, Ph,D.

Sung Han, Ph,D.

Chief Executive Officer

Sung Han joined Kolon TissueGene, Inc. in March, 2020 as the co-Chief Executive Officer. Currently he serves as the CTO of Kolon Group. Before he joined Kolon Group, he served as the Technology Director of Corporate Innovationin Eastman Chemical Company. He received his Ph.D. degree in the Nuclear Engineering at University of California, Berkeley, CA.

Soon-Wook Kweon

Soon-Wook Kweon

Vice President

Soon-Wook Kweon joined Kolon TissueGene, Inc. in May, 2017 as the Chief Financial Officer. Before he joined Kolon TissueGene, he served as the Vice President of the Management & Finance Division in Kolon Corporation. He received his Bachelor of Arts in Economics at Korea University in Korea.

Min Seok Kim

Min Seok Kim

Chief Financial Officer

Min Seok Kim joined Kolon TissueGene, Inc. in October, 2020 as the Chief Financial Officer and the Korea Branch leader. Before he joined Kolon TissueGene, he served as the Financial Director of the Strategic Financing Division in Kolon Benit. He also experienced financial audit and consulting services while working at several accounting firms such as PWC Korea. He received his Bachelor of Arts in Hispanic language & literature at Seoul National University in Korea and acquired his CPA license from Korea Institute of Certified Public Accountant.

Heonsik Choi

Heonsik Choi

VP of Discovery

Heonsik Choi joined Kolon TissueGene, Inc. in June, 2020 as Vice President of Discovery. Also, He is the Vice President of Healthcare Research Institute at Kolon Advanced Research Cluster located at Magok in S. Korea. Before he joined Kolon TissueGene, he served as the Vice President of the Group of New Biological Drug Development in Kolon Life Science. He received his Ph.D. degree in Molecular Immunology at Seoul National University in Korea.